AddLife´s group management
From the left: Peter Simonsbacka, Ove Sandin, Kristina Willgård, Martin Almgren
The CEO, Kristina Willgård, shall manage the operations in accordance with the Companies Act and within the framework established by the Board of Directors. The work and role of the CEO and the division of duties between the Board of Directors and the CEO are detailed in a written set of instructions set out by the Board of Directors (“Instructions to the CEO”). The Board of Directors continuously evaluates the work of the CEO. In consultation with the Chairman, the CEO has prepared the information needed to make decisions at Board meetings and has presented reports and reasoned proposals for decisions.
The CEO shall lead the work of the group management and make decisions in consultation with the other members of the group management. In addition to Kristina Willgård, group management also includes Martin Almgren, CFO, Peter Simonsbacka, Business Area Manager Labtech and Ove Sandin, Business Area Manager Medtech. Until 31 December 2020, Lars-Erik Rydell, Medtech's Business Development Manager, was also part of the group management. Group management has regular business reviews under the management of the CEO.
During the financial year, the Group’s operations were organised into two business areas – Labtech and Medtech. Operations are conducted in subsidiaries in the Nordic region, Central and Eastern Europe, Australia and China. Each operating Company has a board of directors in which the Company’s CEO and senior executives from the business area are represented. Each company president reports to a business division manager or business area manager, who, in turn reports to the CEO for AddLife AB.